Kewajiban jangka dawa marang ekuitas: sintx.com (SINT)

Simbol resmi perusahaan Sintx Technologies, Inc. (SINT)

Ceramic production for implants is low-cyclical and crisis-resistant. The long-term debt-to-equity ratio demonstrates the current financial leverage, where 0.51 represents the current level of the metric. Risks are associated with low liquidity and operating losses. However, the impeccable reputation of Sintx Technologies (SINT) in creating biocompatible materials guarantees surgeon trust and stable demand.

sintx.com (SINT): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Barang utama Sintx Technologies Inc

To identify stability drivers, investors must evaluate the financing structure. This metric is calculated as the ratio of loans with a maturity exceeding one year to equity. By analyzing the level of long-term liabilities relative to equity, one can determine the issuer's degree of financial autonomy. For Sintx Technologies (SINT), this balance is critical when competing with materials science behemoths. A low debt load will ensure the company's survival amid pricing pressure.

Pesaing langsung

Rasio tanggungan utang jangka dawa marang modal BSX|EW - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas ResMed Corporation (RMD)|PODD: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Zimmer ZBH|COO: Utang jangka dawa marang modal|ALGN - Rasio utang jangka dawa marang ekuitas|Globus Medical Corp - Utang jangka dawa marang modal|TransMedics Group, Inc. (TMDX) - Rasio tanggungan utang jangka dawa marang modal|ATEC (Alphatec Holdings, Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal AORT|Utang jangka dawa marang ekuitas Enovis (ENOV)|Utang jangka dawa marang ekuitas Integra LifeSciences Corp (IART)|Utang jangka dawa marang modal ESTA|BBNX - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas IRADIMED CORPORATION|EMBC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal TNDM|AxoGen Inc (AXGN) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal SI-BONE Corp (SIBN)|Rasio utang jangka dawa marang modal Orthofix Corp (OFIX)|Bioventus Inc. (BVS) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal KIDS (orthopediatrics.com)|Treace Medical Concepts, Inc. - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Blade Air Mobility SRTA|CARL (Carlsmed Corp) - Utang jangka dawa marang modal|RXST - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal clearpointneuro.com|stereotaxis.com (STXS) - Rasio utang jangka dawa marang modal|STIM: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Sight Sciences Inc.|Utang jangka dawa marang modal OBIO (Orchestra BioMed)|Rasio utang jangka dawa marang ekuitas anikatherapeutics.com (ANIK)|Utang jangka dawa marang modal NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Utang jangka dawa marang modal|VANI - Utang jangka dawa marang ekuitas|Xtant Medical Holdings (XTNT) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal MYO (Myomo, Inc.)|Kewajiban jangka dawa marang modal COCH|VVOS: Utang jangka dawa marang ekuitas|Tanggungan utang jangka dawa marang ekuitas enVVeno Medical Corporation NVNO|Rasio utang jangka dawa marang ekuitas TNON (Tenon Medical, Inc)|Utang jangka dawa marang modal Lifeward Ltd. LFWD|Utang jangka dawa marang modal AMIX (Autonomix)|IVF: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas BIOL|Rasio utang jangka dawa marang ekuitas Dynatronics Corp.|Paragon 28, Inc. - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal INVO (invobioscience.com)